Heights Capital Management Overview
- Investor Type
- Growth/Expansion
- Status
- Inactive
- Investments
- 27
- Portfolio
- 2
- Exits
- 21
Heights Capital Management General Information
Description
Heights Capital Management was a private equity firm based in San Francisco, California. It was specialized in private investments in public equity in emerging growth companies. It invested in healthcare and technology companies.
Contact Information
Year Founded
1996
Investor Status
Out of Business
Primary Investor Type
Growth/Expansion
Other Investor Types
Venture Capital
Primary Office
- 101 California Street
- Suite 3250
- San Francisco, CA 94111
- United States
Heights Capital Management Investments (27)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| 0000000 | 01-Mar-2022 | 00000 00000 | 000.00 | Drug Discovery | Pre-Clinical Trials | |
| 000000000 | 11-Aug-2021 | 0000 | 000.00 | IT Consulting and Outsourcing | Profitable | |
| 0000000 | 25-Feb-2021 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | |
| 00000000 | 18-Nov-2020 | 00000 00000 | 0000 | Other Devices and Supplies | Generating Revenue/Not Profitable | |
| Cascadian Therapeutics | 30-May-2013 | PIPE | 0000 | Biotechnology | Profitable |
Heights Capital Management Exits (21)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| 000000 00000000000 | 19-Dec-2017 | 000000000000000000 | |
| 000000 00000000000 | 25-Oct-2016 | 000000000000000000 | 00000 |
| 000000000 00000000 | 06-Feb-2015 | 000000 0000000000 | 000.00 |
| 00000 000000000 | 17-Apr-2014 | 000 | 0000 |
| Novadel Pharma | 19-Jul-2013 | Merger/Acquisition |
Heights Capital Management Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trial